• Skip to main content
  • Skip to primary sidebar
virology blog

virology blog

About viruses and viral disease

disease

Herd Immunity and this Pandemic

2 June 2022 by Gertrud U. Rey

by Gertrud U. Rey

Photo courtesy of Andrea Lightfoot photography

Herd immunity occurs when a large enough percentage of the population has acquired either natural or vaccine-induced immunity against an infectious disease, thereby indirectly protecting a minority of non-immune individuals who are dispersed throughout the population. During this pandemic, many prominent scientists have stated that it is impossible to achieve herd immunity in the context of COVID-19, leading some to conclude that a mass SARS-CoV-2 vaccination campaign would be pointless. However, this thinking is flawed, and I want to explain why.

Traditionally, herd immunity is thought to create a barrier for the transmission of infectious agents, resulting not only in prevention of disease, but also prevention of infection. This understanding was based on previous observations that vaccination against poliovirus, measles virus, and other pathogens led to drastic reductions in the incidence of disease burden. It is reasonable to assume that if there is no disease, there is probably also no virus; and hence no viral infection or transmission of virus. However, past vaccination campaigns were not followed up with regular testing programs, so we actually have no way of knowing whether vaccination prevented infection and transmission! Considering that the vast majority of poliovirus infections are asymptomatic, it is possible that some polio virus infections and transmission occurred even after vaccination, despite the fact that those infections did not lead to disease.

The widespread testing measures adopted during the present pandemic have revealed the approximate frequency of asymptomatic SARS-CoV-2 infections, giving us a clearer understanding of the difference and dynamics between disease and infection. The type of immunity that prevents both disease and infection is called sterilizing immunity, and it is mostly thought to be induced by neutralizing antibodies, which inactivate infectious agents before they have a chance to infect a cell, thereby directly neutralizing the biological effect of the agent. However, any immune activity that prevents replication of a pathogen directly or indirectly necessarily induces sterilizing immunity, including the activity of non-neutralizing antibodies, whose binding can trigger other immune functions that can also prevent infection and replication.

Do SARS-CoV-2 vaccines induce sterilizing immunity? The answer to this question is complicated. There are many studies showing that most people have high levels of antibodies in the months following vaccination, and this large proportion of circulating antibodies could likely sequester an incoming virus before it has a chance to enter cells, infect them, and replicate. In this sense, the SARS-CoV-2 vaccines do induce sterilizing immunity, but only within a certain time period after vaccination. As antibody levels contract over time (a normal process), they leave behind a baseline population of memory B cells that can quickly expand and mass-produce new antibodies upon a subsequent encounter with SARS-CoV-2. Likewise, memory T cells can quickly react to incoming virus and virus-triggered signals, and destroy infected cells. Therefore, it is likely that when circulating SARS-CoV-2-specific antibody levels decline months and years after vaccination, the collective activity of memory immune cells will protect one from disease, but probably not infection, meaning that the SARS-CoV-2 vaccines no longer induce sterilizing immunity at that time. In other words, vaccinated people could briefly replicate and transmit low levels of virus, at least until memory immune responses kick in, which then prevent illness and additional viral replication and spread.

The emergence of new variants that are not as well recognized by existing vaccine-induced antibodies may also allow for some increased viral transmission, thus slowing down the establishment of immunity in the population. However, immune responses are not binary, and even a low level immune response that doesn’t protect against infection and spread but prevents serious disease can play a critical role in slowing down the pandemic. Vaccination has historically been very effective at suppressing community outbreaks, despite the fact that most vaccines do not induce sterilizing immunity.

Vaccination or natural immunity do not have to prevent all infections, and immunity does not have to last a lifetime for a pandemic to end. Pediatrician and vaccinologist Paul Offit defines herd immunity as the point where the serious disease burden is reduced sufficiently so as to no longer overwhelm the healthcare system. It’s becoming pretty clear that the pandemic is slowing down in the US, especially in the context of severe disease, hospitalization, and death; and that this is likely due to increased SARS-CoV-2 immunity among US residents. It is therefore likely that reduced illness and a shortened period of transmission from immune individuals will also reduce the overall rate of community infection and transmission. And in the end, it doesn’t matter whether we call it herd immunity, community immunity or some other name; the pandemic will end because a majority of the population is no longer susceptible to severe COVID-19.

[Please check out my video Catch This Episode 29 for an explanation of sterilizing immunity.]

Filed Under: Basic virology, Gertrud Rey Tagged With: antibody, disease, herd immunity, infection, neutralizing antibody, pandemic, sterilizing immunity, transmission, vaccine

TWiM 41: ICAAC live in San Francisco

13 September 2012 by Vincent Racaniello

On episode #41 of the science show This Week in Microbiology, Vincent and Michael travel to San Francisco for the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), where they meet with Bill, John, and Victor to discuss tuberculosis, monitoring infectious disease outbreaks with online data, and outside-the-box approaches to antibacterial therapy.

You can view video of this episode below, or download audio or video files at microbeworld.org.

 

Filed Under: This Week in Microbiology Tagged With: antibacterial, data, disease, Flu, healthmap, icaac, infectious, live, microbe, microbiology, outbreak, San Francisco, tb, therapy, tuberculosis

TWiM 8: Live in NOLA

3 June 2011 by Vincent Racaniello

This Week in Microbiology #8Hosts: Vincent Racaniello, Michael Schmidt, Stan Maloy, Andreas Baümler, Nicole Dubilier, and Paul Rainey.

Vincent, Michael, and Stanley recorded episode #8 of the podcast This Week in Microbiology live at the 2011 ASM General Meeting in New Orleans, with guests Andreas Baümler, Nicole Dubilier, and Paul Rainey. They spoke about how pathogens benefit from disease, symbioses between chemosynthetic bacteria and marine invertebrates, and repetitive sequences in bacteria.

[powerpress url=”http://traffic.libsyn.com/twimshow/TWiM008.mp3″]

Click the arrow above to play, or right click to download TWiM #8 (60 MB, .mp3, 87 minutes).

Subscribe to TWiM (free) on iTunes, Zune Marketplace, via RSS feed, by email or listen on your mobile device with the Microbeworld app.

Links for this episode:

  • Salmonella invasion from the gut lumen into tissues (PLoS Pathogens)
  • Symbiotic diversity in marine animals (Nature Rev Micro)
  • REPINs, a new family of mobile DNA in bacteria (PLoS Genetics)
  • Letters read on TWiM #8
  • Video of TWiM #8 – view below

 

Send your microbiology questions and comments (email or mp3 file) to twim@microbe.tv, or call them in to 908-312-0760. You can also post articles that you would like us to discuss at microbeworld.org and tag them with twim.

Filed Under: This Week in Microbiology Tagged With: andreas, ASM, bacteria, baumler, benefit, chemosynthetic, disease, dubilier, evolution, gastroenteritis, general, invertebrates, live, marine, meeting, new orleans, nicole, pathogens, paul, rainey, repetitive, salmonella, sequences, symbioses, virulence

Influenza A/Mexico/2009 (H1N1): Questions and answers

3 May 2009 by Vincent Racaniello

Here are my answers to questions about the currently circulating influenza H1N1 strain (formerly swine flu) sent by readers of virology blog.

Q: I am concerned about any changes the current AH1N1 virus may undergo as we enter the flu season in the Southern Hemisphere, and when it gets to Indonesia and faces H5N1. What are your expectations, if any of these situations?

I am not concerned about the current A/H1N1 strain recombining with avian H5N1 viruses. The reason is that the incidence of H5N1 viruses
in Asian pigs is low, suggesting that these viruses are not well adapted to pigs. I expect that the H1N1 viruses will undergo antigenic drift as they spread throughout the southern hemisphere, but I don’t anticipate that this will have a major impact on disease this season. There is no reason to believe that the viruses will evolve to a more virulent form.

Q: Has ever been shown sexual dimorphism in influenza? It turns out that 12 are women of 16 deaths blamed to the new influenza virus isolated in Mexico… this is too strange and together with the apparent absence of virulent markers in this new virus points to the presence of confounding factors in Mexico that explain deaths and should reduce the world-wide panic.

A: No, there has never been shown preference for infection, although males are slightly more susceptible to viral infections overall than women. But the difference is slight, and the numbers you cite are too small to draw any conclusions.

Q: Knowing that the Mexico/2009 Influenza A (H1N1) is part of a type of viruses that are unusual in that they copy RNA to DNA in the nucleus of a protein, where one of the segments acts as fusion (HA), and another (NA) aids in transportation to other proteins, isn’t it possible  that this specific one (the Mexico/2009 ) may teach us that there are heretofore unrecognized  innovative strategies in transcription, translation and replication of Influenza viruses?

A: I’m afraid you are misunderstanding the influenza virus replication strategy. The viral RNA is not copied into DNA in cells; the RNA is copied only into RNA. We copy the RNA into DNA to sequence the viral genome. If there were differences in the sequences of the Mexican strains from others we might learn something about viral pathogenicity, but I have not seen such differences so far.

Q: What is the most important protein, which I can use for the preparation  a vaccine against swine influenza?

A: If you had to pick only one viral protein, it would be the HA. This would be a so-called subunit vaccine; they have not been proven yet to be any better than inactivated whole virus vaccine.

Q: If face masks are useless, then why do surgeons wear them when they perform surgery? Sure, nobody with any common sense believes they offer 100% protection, but even a little extra protection is better than none. Another thing that I find outstanding is that nobody seems to be mentioning the use of protective gloves.

A: Face masks are not useless, just not terribly effective because they are not used properly. Surgeons use face masks because they work over exposed tissues and organs, and would otherwise breathe bacteria into the surgical incision. Gloves would become rapidly contaminated; they are useful in certain situations, for example while working in the field in trying to prevent contamination, preventing chemical contamination of the hands, and while working in a cell culture hood so that the cultures are not contaminated by organisms on the skin.

Q: I am a photographer and journalist based in Mexico City, and have been reporting on this outbreak for the last week. I know very little about virology, but have been learning what I can. I started a blog up as a vehicle for some of my observations on the disease and it’s cultural consequences which you can see here: theswine.wordpress.com. So I had a couple questions about this situation, that my be stupid, but any answers you have would be very helpful.

Could this Influenza have originated in these feed lots. (The conditions are horrendous as can be expected in an America run feed lot, without American regulations).

A: This strain of influenza could have originated in any pigs raised for food, as long as humans are working with the pigs.

Q: How could the disease have been transmitted to humans? (The farmers thinks the thick swarms of flies on the sewage lots brought it).

A: The workers have rather close contact with the pigs. They could get it by touching the snout/mouth/respiratory secretions, or alternatively from aersols generated when the pigs breathe. These aerosols contain virus if the pig is infected.

Q: How could it have reached a child in a village with no direct contact with the farms?

A: Someone who had contact with pigs would be infected, then transfer it to the child elsewhere.

Q: I also wonder if contamination could have created a weakened respiratory system that allowed the disease to be more deadly, a theory I can’t help but believe regarding Mexico city which is so profoundly polluted

A: Those who get more severe disease with the same virus that is benign in others, likely have a suboptimal immune response. This can be a consequence of a genetic defect, of concurrent infection with an immunosuppressive microorganism, or environmental factors such as pollution or chemical injury.

Q: Is this normal for flu viruses to mutate into new strains (seemingly) every couple of years? I know it gives conspiracy kooks something new to accuse “The New World Order” of concocting to cause panic. Anyone?

A: Influenza viruses mutate continuously; as a result, new strains arise each year which evade existing immunity and cause epidemics of influenza. Every 20-30 years (or longer) a completely different strain emerges to which there is no prior immunity, and the result is a pandemic. Such new strains emerge from animal hosts, such as birds and pigs.

Q: First, what is the link, if any, between lack of immunity to a virus and the virulence or morbidity of the resulting viral disease?  In other words, should we fear a pandemic because: (1) more people will come down sick than during a normal flu season due the unfamiliarity of the virus; or (2) a higher percentage of the people who get sick will die; or (3) both?

A: Pandemic simply means global epidemic; many people are infected. It does not imply any severity of disease. So more people get sick, and if the strain is no more virulent than yearly influenza, the mortality is 0.1%. If the virus is more virulent (as in 1918) then the mortality is higher, 2.5% for that pandemic.

Q: Second, with respect to airplane travel and travel generally, I think the press and the authorities have done a very poor job distinguishing between systemic risk and personal risk.  Indeed, politicians in particular are hopelessly conflicted on this subject, notwithstanding the vice president’s widely denounced burst of candor.  Is it the case that: (1) while international travel poses no systmetic risk of spreading the virus, which is already present in North and South America, Europe and Asia, (2) individuals nonetheless greatly increase their chances of catching viral disease by traveling on airplanes, staying in hotels, etc.?

A: Yes, as I have written before in this blog, an airplane is a wonderful place to get influenza. But so are schools, workplaces, subways, and so on. We saw how an individual infected with SARS, by staying in a Hong Kong hotel, infected many people who then went on to other cities and spread the infection. Common sense is required. Travel that is not necessary should probably be curtailed.

Q: Finally, I have seen little intelligent discussion of the vastly different countermeasures deployed by different governments.  While everyone scoffs at Egypt, for instance, for slaughtering hundreds of thousands of pigs, no one mentions the radically different responses of the U.S. and Hong Kong authorities.  Has Hong Kong simply got the science wrong when they decide to quarantine hundreds of hotel guests for 10 days?

A: They are probably overreacting to the bad publicity they received with the SARS incident. They should have let the guest go; why should they treat guests any differently from any other locale?

Reader comment: Besides inherent deficiencies in the Mexican health system and initial delays by patients and doctors for a correct diagnosis, there is another scaring possibility for the high death rate in Mexico from the swine flu virus. That possibility is related to the instructions given to the doctors by the Ministery of Health to refrain to treat people with antivirals (Tamiflu, Relenza), unless they already have pulmonary signs (so too late), or they have a chronic disease in addition to the swine flu. Such instruction might save middle aged people (those with chronic diseases) and causes many neumonia cases among the more healthy youngsters. That may parcially explain why not only the death rate is so high, but also the age structure of the affected population. We’ll see if we can solve this questions in the future, because they are full of political consequences.

Q: I understand that with this new, novel strain of virus most, if not all people will not have immunity from previous exposure to the established strains.  However, many (or maybe just some people) will either avoid infection, or become infected yet experience no remarkable symptoms, or maybe just exhibit very mild symptoms rather than get really seriously ill.  What is at work when a person actually is infected yet not really “sick”?  A good immune system that allows infection but contains it quickly? or something else at work? Or just luck at avoiding virus particles? Example – I am 36 years old, and have never been diagnosed, or as far as I know, contracted  influenza.  I have had many other common ailments (many bouts of strep and colds, chicken pox, mononucleosis) over my years, but seemingly not flu virus.  I have never been vaccinated against flu.  What could account for this? Luck?  I find it impossible I haven’t ever come in contact with flu virus.  Assuming I have had contact with flu virus, why no remarkable illness for me? Clearly other infections can occur in me.  Are some people “immune” to all types of flu or react to it differently than others who suffer the common symptoms?

A: Our understanding of susceptibility to viral infection is rudimentary. When populations of humans or other animals are infected, many different responses may occur. Some people may be highly resistant, others may become infected, and some may fall in between. Of those infected, some may show clinical symptoms while others do not. Susceptibility to infection and disease vary independently. Some determinants include the immune system – your system may simply be more robust than the next person’s. There are genetic determinants of susceptibility; specific genes that regulate whether you can be infected or not. Age of the host, nutritional status, gender, cigarette smoking, mental status, and air pollution are some of the known factors.

Filed Under: Information Tagged With: disease, H1N1, infection, influenza, pandemic, susceptibility, swine flu, viral, virology, virus

Primary Sidebar

by Vincent Racaniello

Earth’s virology Professor
Questions? virology@virology.ws

With David Tuller and
Gertrud U. Rey

Follow

Facebook, Twitter, YouTube, Instagram
Get updates by RSS or Email

Contents

Table of Contents
ME/CFS
Inside a BSL-4
The Wall of Polio
Microbe Art
Interviews With Virologists

Earth’s Virology Course

Virology Live
Columbia U
Virologia en Español
Virology 101
Influenza 101

Podcasts

This Week in Virology
This Week in Microbiology
This Week in Parasitism
This Week in Evolution
Immune
This Week in Neuroscience
All at MicrobeTV

Useful Resources

Lecturio Online Courses
HealthMap
Polio eradication
Promed-Mail
Small Things Considered
ViralZone
Virus Particle Explorer
The Living River
Parasites Without Borders

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.